文献速递复苏、休克与脓毒症心脑血管急症

院外心脏骤停中平均肾上腺素给药间隔与出院时良好神经功能生存的关联

The Association of the Average Epinephrine Dosing Interval and Survival With Favorable Neurologic Status at Hospital Discharge in Out-of-Hospital Cardiac Arrest.
PubMed 文献 · Ann Emerg Med · 2019-06-24
一句话结论院外心脏骤停中,较短的肾上腺素平均给药间隔与出院时良好神经功能生存相关。

该研究为复苏结局联盟持续胸外按压试验的二次分析,纳入接受≥2剂肾上腺素的连续院外心脏骤停患者15,909例。平均给药间隔定义为首剂后复苏时长除以肾上腺素总剂量,分为<3、3-<4、4-<5、≥5分钟四组。以<3分钟为参照,较长间隔与出院时良好神经功能生存(改良Rankin量表评分≤3)降低相关,调整比值比分别为0.44、0.26和0.21。

要点

  • 共纳入15,909例接受≥2剂肾上腺素的院外心脏骤停患者,出院时良好神经功能生存率为4.7%。
  • 中位肾上腺素给药间隔为4.3分钟(四分位距3.5-5.3分钟)。
  • 与给药间隔<3分钟相比,3-<4分钟组良好神经功能生存的调整比值比为0.44(95%CI 0.32-0.60)。
  • 与给药间隔<3分钟相比,4-<5分钟组和≥5分钟组的调整比值比分别为0.26(95%CI 0.18-0.36)和0.21(95%CI 0.15-0.30)。
  • 作者结论认为,较短的肾上腺素平均给药间隔与更好的良好神经功能生存相关。

适用人群与场景

  • 院外心脏骤停且接受≥2剂肾上腺素的连续患者。

诊断标准与关键阈值

  • 良好神经功能生存定义为出院时改良Rankin量表评分≤3。
  • 平均肾上腺素给药间隔定义为首剂肾上腺素后复苏时长除以肾上腺素总给药剂量,按分钟分为<3、3-<4、4-<5、≥5四组。

研究设计与关键结果

  • 研究类型为复苏结局联盟持续胸外按压试验的二次分析,纳入15,909例患者,中位年龄68岁(四分位距56-80岁),女性35%,公共场所13%,旁观者心肺复苏46%,初始可除颤心律19%。
  • 中位肾上腺素给药间隔为4.3分钟(四分位距3.5-5.3分钟),出院时良好神经功能生存率为4.7%。
  • 以给药间隔<3分钟为参照,3-<4分钟组调整比值比0.44(95%CI 0.32-0.60),4-<5分钟组调整比值比0.26(95%CI 0.18-0.36),≥5分钟组调整比值比0.21(95%CI 0.15-0.30)。

证据类型、等级与局限

  • 证据类型为对复苏结局联盟持续胸外按压试验的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在院外心脏骤停系列中,较短的肾上腺素平均给药间隔与出院时良好神经功能生存改善相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: For patients with out-of-hospital cardiac arrest, the recommended dosing interval of epinephrine is 3 to 5 minutes, but this recommendation is based on expert opinion without data to guide optimal management. We seek to evaluate the association between the average epinephrine dosing interval and patient outcomes.

METHODS: In a secondary analysis of the Resuscitation Outcomes Consortium continuous chest compression trial, we identified consecutive patients treated with greater than or equal to 2 doses of epinephrine. We defined average epinephrine dosing interval as resuscitation duration after the first dose of epinephrine divided by the total administered epinephrine, and categorized the dosing interval in minutes as less than 3, 3 to less than 4, 4 to less than 5, and greater than or equal to 5. We fit a logistic regression model to estimate the association of the average epinephrine dosing interval category with survival with favorable neurologic status (modified Rankin Scale score ≤3) at hospital discharge.

RESULTS: We included 15,909 patients (median age 68 years [interquartile range 56 to 80 years], 35% women, 13% public location, 46% bystander cardiopulmonary resuscitation, and 19% initial shockable rhythm). The median epinephrine dosing interval was 4.3 minutes (interquartile range 3.5 to 5.3 minutes). Survival with favorable neurologic status occurred in 4.7% of patients. Compared with the reference dosing interval of less than 3 minutes, longer epinephrine dosing intervals were associated with lower survival with favorable neurologic status: dosing interval 3 to less than 4 minutes, adjusted odds ratio 0.44 (95% confidence interval 0.32 to 0.60); 4 to less than 5 minutes, adjusted odds ratio 0.26 (95% confidence interval 0.18 to 0.36); and greater than or equal to 5 minutes, adjusted odds ratio 0.21 (95% confidence interval 0.15 to 0.30).

CONCLUSION: In this out-of-hospital cardiac arrest series, a shorter average epinephrine dosing interval was associated with improved survival with favorable neurologic status.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Grunau B, Kawano T, Scheuermeyer FX, et al. The Association of the Average Epinephrine Dosing Interval and Survival With Favorable Neurologic Status at Hospital Discharge in Out-of-Hospital Cardiac Arrest. Ann Emerg Med. 2019. PMID: 31248676. doi:10.1016/j.annemergmed.2019.04.031

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。